<SEC-DOCUMENT>0001213900-20-006918-index.html : 20200320 <SEC-HEADER>0001213900-20-006918.hdr.sgml : 20200320 <ACCEPTANCE-DATETIME>20200319213145 ACCESSION NUMBER: 0001213900-20-006918 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20200106 ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200320 DATE AS OF CHANGE: 20200319 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ArTara Therapeutics, Inc. CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36694 FILM NUMBER: 20730030 BUSINESS ADDRESS: STREET 1: 1 LITTLE WEST 12TH STREET CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 646-844-0337 MAIL ADDRESS: STREET 1: 1 LITTLE WEST 12TH STREET CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: PROTEON THERAPEUTICS INC DATE OF NAME CHANGE: 20060420 </SEC-HEADER> <DOCUMENT> <TYPE>8-K/A <SEQUENCE>1 <FILENAME>ea119633-8ka_artaratherap.htm <DESCRIPTION>AMENDMENT TO FORM 8-K <TEXT> Document 1 - file: ea119633-8ka_artaratherap.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>2 <FILENAME>ea119633ex23-1_artaratherap.htm <DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM <TEXT> Document 2 - file: ea119633ex23-1_artaratherap.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>3 <FILENAME>ea119633ex99-1_artaratherap.htm <DESCRIPTION>AUDITED FINANCIAL STATEMENTS OF ARTARA SUBSIDIARY, INC. AS OF DECEMBER 31, 2019 AND 2018 AND FOR THE YEARS ENDED DECEMBER 31, 2019 AND 2018 <TEXT> Document 3 - file: ea119633ex99-1_artaratherap.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>4 <FILENAME>ea119633ex99-2_artaratherap.htm <DESCRIPTION>UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS <TEXT> Document 4 - file: ea119633ex99-2_artaratherap.htm
</DOCUMENT> </SEC-DOCUMENT>